
Motidom 20mg Tablet DT
Marketer
Tas Med India Pvt Ltd
Salt Composition
Domperidone (20mg)
Overview Motidom 20mg Tablet DT
Gastric relief medication Motidom 20mg Tablet DT addresses indigestion, nausea, and vomiting symptoms. It accelerates gastrointestinal transit, alleviating bloating, satiety, and stomach distress. Administer Motidom 20mg Tablet DT thirty minutes prior to meals, following your physician's prescribed dosage and duration. Dosage is individualized based on your response and condition; continue treatment as directed. Inform your doctor of all concurrent medications, as interactions are possible. Headache, dry mouth, and abdominal pain are prevalent, typically transient side effects. Report any concerning side effects immediately. Dizziness is also possible; avoid driving or mentally demanding tasks until its impact is known. Alcohol consumption should be avoided due to potential side effect exacerbation. Diarrhea is a potential adverse effect; increased fluid intake is recommended to prevent dehydration. Disclose liver or kidney conditions to your doctor before starting treatment. Avoid concurrent antacid use. Pregnant individuals require medical consultation before using this medication. Patients with active peptic ulcers should refrain from using Motidom 20mg Tablet DT.
Primary Ingredients of Motidom 20mg Tablet DT
No text was provided to rewrite.
Uses of Motidom 20mg Tablet DT
Managing indigestion, nausea, and vomiting.
Major Benefits of Motidom 20mg Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Motidom 20mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Motidom 20mg Tablet DT:
- Headache
- Dryness in mouth
- Stomach pain
- Diarrhea
How to use Motidom 20mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Motidom 20mg Tablet DT in water before consumption. Administer on an empty stomach.
How Motidom 20mg Tablet DT works:
Motidom 20mg Delayed-Release Tablets stimulate gastrointestinal motility. This medication targets the brain's emetic center to suppress nausea and vomiting. Furthermore, it enhances upper gastrointestinal peristalsis, facilitating the efficient passage of food through the stomach.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Motidom 20mg Tablet DT is not advised without prior medical consultation. A physician should be consulted regarding the safety of concomitant use.
PregnancyCONSULT YOUR DOCTOR
The use of Motidom 20mg Tablet DT during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Motidom 20mg Delayed-Release Tablets while breastfeeding is considered safe. Research in humans indicates minimal drug transfer into breast milk, posing no known threat to the infant.
DrivingUNSAFE
Taking Motidom 20mg Delayed-Release Tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Caution is advised when prescribing Motidom 20mg Tablet DT to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Caution is advised when prescribing Motidom 20mg Tablet DT to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Motidom 20mg Tablet DT is contraindicated in patients exhibiting moderate to severe liver dysfunction.
What if you forget to take Motidom 20mg Tablet DT :
Should you forget to take a Motidom 20mg Tablet DT, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Motidom 20mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Prokinetic agent with dopamine D2 receptor antagonism |
